These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37952548)

  • 21. Oxytocin for preventing postpartum haemorrhage (PPH) in non-facility birth settings.
    Pantoja T; Abalos E; Chapman E; Vera C; Serrano VP
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011491. PubMed ID: 27078125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidural versus non-epidural or no analgesia for pain management in labour.
    Anim-Somuah M; Smyth RM; Cyna AM; Cuthbert A
    Cochrane Database Syst Rev; 2018 May; 5(5):CD000331. PubMed ID: 29781504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Misoprostol with balloon vs oxytocin with balloon in high-risk pregnancy induction: a randomized controlled trial.
    Al-Hafez L; Khanuja K; Mendez-Figueroa H; Al-Kouatly HB; Mascio DD; Chauhan SP; Berghella V
    Am J Obstet Gynecol MFM; 2023 Dec; 5(12):101175. PubMed ID: 37806650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral Misoprostol alone versus oral misoprostol followed by oxytocin for labour induction in women with hypertension in pregnancy (MOLI): protocol for a randomised controlled trial.
    Bracken H; Lightly K; Mundle S; Kerr R; Faragher B; Easterling T; Leigh S; Turner M; Alfirevic Z; Winikoff B; Weeks A
    BMC Pregnancy Childbirth; 2021 Jul; 21(1):537. PubMed ID: 34325670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxytocin receptor antagonists for inhibiting preterm labour.
    Flenady V; Reinebrant HE; Liley HG; Tambimuttu EG; Papatsonis DN
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD004452. PubMed ID: 24903678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more).
    Middleton P; Shepherd E; Flenady V; McBain RD; Crowther CA
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD005302. PubMed ID: 28050900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the type of maternal pushing during the second stage of labour on obstetric and neonatal outcome: a multicentre randomised trial-the EOLE study protocol.
    Barasinski C; Vendittelli F
    BMJ Open; 2016 Dec; 6(12):e012290. PubMed ID: 27998899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of labour at 41 weeks versus expectant management and induction of labour at 42 weeks (SWEdish Post-term Induction Study, SWEPIS): multicentre, open label, randomised, superiority trial.
    Wennerholm UB; Saltvedt S; Wessberg A; Alkmark M; Bergh C; Wendel SB; Fadl H; Jonsson M; Ladfors L; Sengpiel V; Wesström J; Wennergren G; Wikström AK; Elden H; Stephansson O; Hagberg H
    BMJ; 2019 Nov; 367():l6131. PubMed ID: 31748223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maximum Dose Rate of Intrapartum Oxytocin Infusion and Associated Obstetric and Perinatal Outcomes.
    Son M; Roy A; Grobman WA; Miller ES; Dude A; Peaceman AM; Stetson B
    Obstet Gynecol; 2023 Feb; 141(2):379-386. PubMed ID: 36649339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous versus intramuscular prophylactic oxytocin for the third stage of labour.
    Oladapo OT; Okusanya BO; Abalos E; Gallos ID; Papadopoulou A
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD009332. PubMed ID: 33169839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immediate delivery compared with expectant management after preterm pre-labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial.
    Morris JM; Roberts CL; Bowen JR; Patterson JA; Bond DM; Algert CS; Thornton JG; Crowther CA;
    Lancet; 2016 Jan; 387(10017):444-52. PubMed ID: 26564381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uterotonic agents for first-line treatment of postpartum haemorrhage: a network meta-analysis.
    Parry Smith WR; Papadopoulou A; Thomas E; Tobias A; Price MJ; Meher S; Alfirevic Z; Weeks AD; Hofmeyr GJ; Gülmezoglu AM; Widmer M; Oladapo OT; Vogel JP; Althabe F; Coomarasamy A; Gallos ID
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD012754. PubMed ID: 33232518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxytocin versus prostaglandins for labour Induction of women with an unfavourable cervix after 24 hours of cervical ripening (OPIC): protocol for an open multicentre randomised non-inferiority trial.
    De Berti M; Le Gouge A; Monmousseau F; Gallot D; Sentilhes L; Winer N; Legendre G; Desbriere R; Girault A; Pozzi J; Gachon B; Barjat T; Perrotin F; Brunet-Houdard S; Diguisto C;
    BMJ Open; 2023 Apr; 13(4):e058282. PubMed ID: 37068892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Misoprostol for induction of labour: a systematic review.
    Hofmeyr GJ; Gülmezoglu AM; Alfirevic Z
    Br J Obstet Gynaecol; 1999 Aug; 106(8):798-803. PubMed ID: 10453829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxytocin augmentation of labour in women with epidural analgesia for reducing operative deliveries.
    Costley PL; East CE
    Cochrane Database Syst Rev; 2012 May; (5):CD009241. PubMed ID: 22592738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxytocin augmentation of labour in women with epidural analgesia for reducing operative deliveries.
    Costley PL; East CE
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD009241. PubMed ID: 23846738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of labor with misoprostol for premature rupture of membranes beyond thirty-six weeks' gestation.
    Wing DA; Paul RH
    Am J Obstet Gynecol; 1998 Jul; 179(1):94-9. PubMed ID: 9704771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discontinuing Oxytocin Infusion in the Active Phase of Labor: A Systematic Review and Meta-analysis.
    Saccone G; Ciardulli A; Baxter JK; Quiñones JN; Diven LC; Pinar B; Maruotti GM; Martinelli P; Berghella V
    Obstet Gynecol; 2017 Nov; 130(5):1090-1096. PubMed ID: 29016497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of labour at 41 weeks versus expectant management until 42 weeks (INDEX): multicentre, randomised non-inferiority trial.
    Keulen JK; Bruinsma A; Kortekaas JC; van Dillen J; Bossuyt PM; Oudijk MA; Duijnhoven RG; van Kaam AH; Vandenbussche FP; van der Post JA; Mol BW; de Miranda E
    BMJ; 2019 Feb; 364():l344. PubMed ID: 30786997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy and safety of 25 μg or 50 μg oral misoprostol versus 25 μg vaginal misoprostol given at 4- or 6-hourly intervals for induction of labour in women at or beyond term with live singleton pregnancies: A systematic review and meta-analysis.
    Yenuberi H; Mathews J; George A; Benjamin S; Rathore S; Tirkey R; Tharyan P
    Int J Gynaecol Obstet; 2024 Feb; 164(2):482-498. PubMed ID: 37401143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.